Target intelligence / Profile preview

MHC class I H2-Kb heavy chain (H2-Kb)

Target
H2-Kb
Molecular classification
MHC class I, Receptor
01

Overview

The MHC class I H2-Kb heavy chain is a classical major histocompatibility complex class I molecule expressed on nearly all nucleated cells in mice, forming a heterodimer with beta-2-microglobulin to present 8-10 residue peptides derived from intracellular proteins in a groove formed by alpha1 and alpha2 domains flanked by alpha-helices. This presentation enables recognition by CD8+ cytotoxic T lymphocytes via their T cell receptors, triggering targeted cell killing to eliminate virus-infected or malignant cells, thus mediating adaptive cellular immunity against intracellular pathogens like viruses and certain bacteria. H2-Kb also interacts with CD8 to enhance T cell signaling and serves as an inhibitory ligand for natural killer cells to prevent lysis of healthy self-cells. Beyond immunity, H2-Kb negatively regulates proliferation of neural stem and progenitor cells by modulating growth factor signaling and cell cycle progression, independent of immune functions, influencing adult hippocampal neurogenesis. While not a direct small-molecule drug target, its role in antigen presentation makes it central to immunotherapies like peptide vaccines or checkpoint inhibitors in cancer and infectious diseases, though genetic deficiency reveals risks like impaired CD8+ T cell memory and NK cell calibration. Structural studies confirm allele-specific peptide binding, with H2-Kb accommodating specific anchors in its closed-end groove.

Other names
H-2KbH2-K^bH-2K^b
02

Biological functions

Antigen presentationImmune responseCellular immunityNegative regulation of neural progenitor cell proliferation
03

Disease associations

InfectionCancerNeurodegenerative disease
04

Safety considerations

Potential disruption of immune surveillance leading to increased infection susceptibility or autoimmunitymodulation of neurogenesis may affect brain repair

Beyond the preview

Go deeper on MHC class I H2-Kb heavy chain (H2-Kb).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MHC class I H2-Kb heavy chain (H2-Kb).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call